Dow Down 0.92% Nasdaq Down 0.83%

Gilead Sciences Inc. (GILD)

-NasdaqGS
106.09 Down 0.58(0.54%) 4:00PM EDT
|After Hours : 104.70 Down 1.39 (1.31%) 7:17PM EDT - Nasdaq Real Time Price
Prev Close:106.67
Open:106.78
Bid:104.45 x 100
Ask:104.85 x 1000
1y Target Est:118.08
Beta:0.98
Next Earnings Date:28-Oct-14GILD Earnings announcement
Day's Range:104.07 - 107.00
52wk Range:63.50 - 110.64
Volume:13,757,485
Avg Vol (3m):14,420,100
Market Cap:160.37B
P/E (ttm):24.03
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for GILD

Comparison

Symbol% ChgMkt Cap
GILDDown 0.54%160.37B
GSKUp 1.79%106.67B
PFEUp 0.07%179.45B
RHHBYDown 0.10%247.03B

Key Statistics

Forward P/E (1 yr):10.99
P/S (ttm):9.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.05
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback